Mestastop Solutions

Executive Summary

Mestastop Solutions is an Indian biotechnology company focused on preventing cancer metastasis through a proprietary platform that integrates wet lab biology with machine learning. Founded in 2020 and based in Bangalore, the company specializes in dissecting metastasis biology into functional assays to drive drug discovery, repurposing, and companion diagnostics. With a team of 10–50 employees, Mestastop operates at the platform stage, aiming to address a critical unmet need in oncology: preventing the spread of cancer, which is responsible for the majority of cancer-related deaths. While the company has not disclosed any funding rounds or revenues, its technology has the potential to significantly impact metastasis research and treatment. The absence of disclosed financials and early-stage nature contribute to a moderate conviction score of 55, reflecting both promise and uncertainty. Key upcoming catalysts include potential series A financing, strategic pharma partnerships, and preclinical data readouts that could validate its platform and attract further investment.

Upcoming Catalysts (preview)

• Q1 2027Series A Funding Round60% success
• Q4 2026Pharma Partnership for Metastasis Drug Repurposing50% success
• Q3 2026Preclinical Proof-of-Concept Data Release70% success